Related references
Note: Only part of the references are listed.Identification of novel selective P2Y6 receptor antagonists by high-throughput screening assay
Masaaki Ito et al.
LIFE SCIENCES (2017)
Anti-proliferative Effects of Nucleotides on Gastric Cancer via a Novel P2Y6/SOCE/Ca2+/β-catenin Pathway
Hanxing Wan et al.
SCIENTIFIC REPORTS (2017)
South (S)- and North (N)-Methanocarba-7-Deazaadenosine Analogues as Inhibitors of Human Adenosine Kinase
Kiran S. Toti et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
New insights on pyrimidine signalling within the arterial vasculature - Different roles for P2Y2 and P2Y6 receptors in large and small coronary arteries of the mouse
Kristian Agmund Haanes et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2016)
Pharmacology and structure of P2Y receptors
Ivar von Kuegelgen et al.
NEUROPHARMACOLOGY (2016)
Purinergic P2Y6 receptors heterodimerize with angiotensin AT1 receptors to promote angiotensin II-induced hypertension
Akiyuki Nishimura et al.
SCIENCE SIGNALING (2016)
Chemotherapy-induced uridine diphosphate release promotes breast cancer metastasis through P2Y6 activation
Xiaobin Ma et al.
ONCOTARGET (2016)
Purinergic P2Y6 receptors heterodimerize with angiotensin AT1 receptors to promote angiotensin II-induced hypertension
Akiyuki Nishimura et al.
SCIENCE SIGNALING (2016)
Purinergic signaling in the immune system
Francesco Di Virgilio et al.
AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL (2015)
Synthesis and structure-activity relationship of uracil nucleotide derivatives towards the identification of human P2Y6 receptor antagonists
Diana Meltzer et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
The Absence of Purinergic G Protein-Coupled Receptor 6 on Dendritic Cells Amplifies Antigen-Induced Pulmonary Inflammation
Laura B. Fanning et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
Two disparate ligand-binding sites in the human P2Y1 receptor
Dandan Zhang et al.
NATURE (2015)
Efficient, large-scale synthesis and preclinical studies of MRS5698, a highly selective A3 adenosine receptor agonist that protects against chronic neuropathic pain
Dilip K. Tosh et al.
PURINERGIC SIGNALLING (2015)
Nucleotides Acting at P2Y Receptors: Connecting Structure and Function
Kenneth A. Jacobson et al.
MOLECULAR PHARMACOLOGY (2015)
Inhibition of UDP/P2Y6 Purinergic Signaling Prevents Phagocytosis of Viable Neurons by Activated Microglia In Vitro and In Vivo
Jonas J. Neher et al.
GLIA (2014)
4-Alkyloxyimino Derivatives of Uridine-5′-triphosphate: Distal Modification of Potent Agonists as a Strategy for Molecular Probes of P2Y2, P2Y4, and P2Y6 Receptors
P. Suresh Jayasekara et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
5-OMe-uridine-5′-O-(α-boranodiphosphate), a novel nucleotide derivative highly active at the human P2Y6 receptor protects against death-receptor mediated glial apoptosis
Michael Haas et al.
NEUROSCIENCE LETTERS (2014)
Enhancement of Glucose Uptake in Mouse Skeletal Muscle Cells and Adipocytes by P2Y6 Receptor Agonists
Ramachandran Balasubramanian et al.
PLOS ONE (2014)
P2Y6 Receptor Potentiates Pro-Inflammatory Responses in Macrophages and Exhibits Differential Roles in Atherosclerotic Lesion Development
Ricardo A. Garcia et al.
PLOS ONE (2014)
AMP-activated protein kinase as regulator of P2Y6 receptor-induced insulin secretion in mouse pancreatic β-cells
Ramachandran Balasubramanian et al.
BIOCHEMICAL PHARMACOLOGY (2013)
Synthesis and Biological Evaluation of Methylenecyclopropane Analogues of Nucleosides
Germain Obame et al.
SYNTHESIS-STUTTGART (2013)
4-Alkyloxyimino-cytosine nucleotides: tethering approaches to molecular probes for the P2Y6 receptor
P. Suresh Jayasekara et al.
MEDCHEMCOMM (2013)
UDP made a highly promising stable, potent, and selective P2Y6-receptor agonist upon introduction of a boranophosphate moiety
Tamar Ginsburg-Shmuel et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2012)
P2Y6 receptor contributes to neutrophil recruitment to inflamed intestinal mucosa by increasing CXC chemokine ligand 8 expression in an AP-1-dependent manner in epithelial cells
Djordje M. Grbic et al.
INFLAMMATORY BOWEL DISEASES (2012)
Automated design of ligands to polypharmacological profiles
Jeremy Besnard et al.
NATURE (2012)
Sulfonyl Imidazolium Salts as Reagents for the Rapid and Efficient Synthesis of Nucleoside Polyphosphates and Their Conjugates
Samy Mohamady et al.
ORGANIC LETTERS (2012)
Purinergic Receptor Type 6 Contributes to Airway Inflammation and Remodeling in Experimental Allergic Airway Inflammation
Rodolfo Paula Vieira et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Selective induction of endothelial P2Y6 nucleotide receptor promotes vascular inflammation
Ann-Kathrin Riegel et al.
BLOOD (2011)
Structural Modifications of UMP, UDP, and UTP Leading to Subtype-Selective Agonists for P2Y2, P2Y4, and P2Y6 Receptors
Ali El-Tayeb et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
P2Y receptors and atherosclerosis in apolipoprotein E-deficient mice
Pieter-Jan D. F. Guns et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
The G(q)/G(11)-mediated signaling pathway is critical for autocrine potentiation of insulin secretion in mice
Antonia Sassmann et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
5-OMe-UDP is a Potent and Selective P2Y6-Receptor Agonist
Tamar Ginsburg-Shmuel et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Pyrimidine Ribonucleotides with Enhanced Selectivity as P2Y6 Receptor Agonists: Novel 4-Alkyloxyimino, (S)-Methanocarba, and 5′-Triphosphate γ-Ester Modifications
Hiroshi Maruoka et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Molecular recognition in the P2Y14 receptor: Probing the structurally permissive terminal sugar moiety of uridine-5′-diphosphoglucose
Hyojin Ko et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2009)
Uridine diphosphate (UDP) stimulates insulin secretion by activation of P2Y6 receptors
Fariborz Parandeh et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Synthesis and potency of novel uracil nucleotides and derivatives as P2Y2 and P2Y6 receptor agonists
Hyojin Ko et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
Hypotensive effect of UDP on intraocular pressure in rabbits
Anna Markovskaya et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Synthesis of enantiomerically pure (S)-methanocarbaribo uracil nucleoside derivatives for use as antiviral agents and P2Y receptor ligands
Artem Melman et al.
JOURNAL OF ORGANIC CHEMISTRY (2008)
Attenuation of apoptosis in vitro and ischemia/reperfusion injury in vivo in mouse skeletal muscle by P2Y6 receptor activation
Liaman K. Mamedova et al.
PHARMACOLOGICAL RESEARCH (2008)
UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis
Schuichi Koizumi et al.
NATURE (2007)
Enantiomeric synthesis of carbocyclic D-4′-C-methyl-ribonucleosides as potential antiviral agents
Peng Liu et al.
TETRAHEDRON-ASYMMETRY (2006)
Structure-activity relationships of uridine 5′-diphosphate analogues at the human P2Y6 receptor
Pedro Besada et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Positive inotropic effects by uridine triphosphate (UTP) and uridine diphosphate (UDP) via P2Y2 and P2Y6 receptors on cardiomyocytes and release of UTP in man during myocardial infarction
AK Wihlborg et al.
CIRCULATION RESEARCH (2006)
International union of pharmacology LVIII: Update on the P2Y G protein-coupled nucleotide receptors: From molecular mechanisms and pathophysiology to therapy
Maria P. Abbracchio et al.
PHARMACOLOGICAL REVIEWS (2006)
Human P2Y6 receptor:: Molecular modeling leads to the rational design of a novel agonist based on a unique conformational preference
S Costanzi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
P2Y6 nucleotide receptors activate NF-κB and increase survival of osteoclasts
J Korcok et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
A direct method for the synthesis of nucleoside 5'-methylenebis(phosphonate)s from nucleosides
M Kalek et al.
TETRAHEDRON LETTERS (2005)
Synthesis and biological evaluation of 5-substituted derivatives of the potent antiherpes agent (north)-methanocarbathymine
P Russ et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
P2Y6 nucleotide receptor activates PKC to protect 1321N1 astrocytoma cells against tumor necrosis factor-induced apoptosis
SG Kim et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2003)
Tumor necrosis factor α-induced apoptosis in astrocytes is prevented by the activation of P2Y6, but not P2Y4 nucleotide receptors
SG Kim et al.
BIOCHEMICAL PHARMACOLOGY (2003)
Methanocarba modification of uracil and adenine nucleotides:: High potency of northern ring conformation at P2Y1, P2Y2, P2Y4, and P2Y11 but not P2Y6 receptors
HS Kim et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Share Paper
